Huangpu Biomedical Industry Investment Fund
Overview
Huangpu Biomedical Industry Investment Fund is a private equity investment management institution focused on the life sciences and healthcare industry, with investments in biopharmaceuticals, innovative medical devices, and synthetic biology. Its main sponsors include Guangzhou Development District Holding Group, Liding Capital, BeiGene, and Guoju Venture Capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Guangzhou Virotech Pharmaceutical Co., Ltd. | Feb 2021 | Series C | Co-investor |
| Suzhou Forlong Biotechnology Co., Ltd. | Feb 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Huangpu Biomedical Industry Investment Fund based?
Huangpu Biomedical Industry Investment Fund is headquartered in Guangzhou, China.
When was Huangpu Biomedical Industry Investment Fund founded?
Huangpu Biomedical Industry Investment Fund was founded in 2019.
How many portfolio companies does Huangpu Biomedical Industry Investment Fund have?
Huangpu Biomedical Industry Investment Fund has 2 portfolio companies in Caplight's dataset.
What are some companies in Huangpu Biomedical Industry Investment Fund's portfolio?
Portfolio companies visible on Caplight include Guangzhou Virotech Pharmaceutical Co., Ltd., Suzhou Forlong Biotechnology Co., Ltd..
What was Huangpu Biomedical Industry Investment Fund's most recent investment shown here?
Huangpu Biomedical Industry Investment Fund's most recent investment in this portfolio sample was in Suzhou Forlong Biotechnology Co., Ltd. in 2023.
What sectors does Huangpu Biomedical Industry Investment Fund focus on?
Huangpu Biomedical Industry Investment Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Huangpu Biomedical Industry Investment Fund focus on?
Stage focus information for Huangpu Biomedical Industry Investment Fund is not publicly available.